Stocktoria
vTv Therapeutics Inc. VTVT
vTv Therapeutics Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -2377.6% | — | -1116.9% | -540.9% | -184.8% | -755.9% | -159.4% | -17416.5% | -8678.2% |
| Net margin | — | -1815.3% | — | -949.7% | -324.3% | -132.5% | -471.9% | -63.6% | -5547.8% | -2579.2% |
| FCF margin | — | -2488.4% | — | -795.0% | -482.1% | -280.6% | -835.3% | -216.0% | -15332.3% | -7617.7% |
| Return on assets | -30.0% | -48.2% | -183.8% | -57.7% | -51.0% | -57.5% | -140.8% | -92.4% | -57.8% | -30.0% |
| Return on equity | -41.9% | -129.1% | 82.1% | 178.4% | 133.3% | 10.6% | 26.6% | 9.5% | 10.7% | 18.0% |
| Debt / equity | — | — | — | — | — | — | -0.10× | -0.18× | — | -0.12× |
| Current ratio | 13.54 | 7.34 | 1.00 | 3.52 | 1.84 | 1.13 | 0.21 | 0.18 | 0.76 | 4.56 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.